Literature DB >> 31276437

Multiple origins of reverse transcriptases linked to CRISPR-Cas systems.

Nicolás Toro1, Francisco Martínez-Abarca1, Mario Rodríguez Mestre1, Alejandro González-Delgado1.   

Abstract

Prokaryotic genomes harbour a plethora of uncharacterized reverse transcriptases (RTs). RTs phylogenetically related to those encoded by group-II introns have been found associated with type III CRISPR-Cas systems, adjacent or fused at the C-terminus to Cas1. It is thought that these RTs may have a relevant function in the CRISPR immune response mediating spacer acquisition from RNA molecules. The origin and relationships of these RTs and the ways in which the various protein domains evolved remain matters of debate. We carried out a large survey of annotated RTs in databases (198,760 sequences) and constructed a large dataset of unique representative sequences (9,141). The combined phylogenetic reconstruction and identification of the RTs and their various protein domains in the vicinity of CRISPR adaptation and effector modules revealed three different origins for these RTs, consistent with their emergence on multiple occasions: a larger group that have evolved from group-II intron RTs, and two minor lineages that may have arisen more recently from Retron/retron-like sequences and Abi-P2 RTs, the latter associated with type I-C systems. We also identified a particular group of RTs associated with CRISPR-cas loci in clade 12, fused C-terminally to an archaeo-eukaryotic primase (AEP), a protein domain (AE-Prim_S_like) forming a particular family within the AEP proper clade. Together, these data provide new insight into the evolution of CRISPR-Cas/RT systems.

Entities:  

Keywords:  Abi; CRISPR; Cas; archaeo-eukaryotic primase; diversity-generating retroelement; group II intron; retron; reverse transcriptase

Mesh:

Substances:

Year:  2019        PMID: 31276437      PMCID: PMC6779382          DOI: 10.1080/15476286.2019.1639310

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  44 in total

Review 1.  Group II introns: mobile ribozymes that invade DNA.

Authors:  Alan M Lambowitz; Steven Zimmerly
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

2.  Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase-Cas1 fusion protein.

Authors:  Sukrit Silas; Georg Mohr; David J Sidote; Laura M Markham; Antonio Sanchez-Amat; Devaki Bhaya; Alan M Lambowitz; Andrew Z Fire
Journal:  Science       Date:  2016-02-26       Impact factor: 47.728

3.  Functionally diverse type V CRISPR-Cas systems.

Authors:  Winston X Yan; Pratyusha Hunnewell; Lauren E Alfonse; Jason M Carte; Elise Keston-Smith; Shanmugapriya Sothiselvam; Anthony J Garrity; Shaorong Chong; Kira S Makarova; Eugene V Koonin; David R Cheng; David A Scott
Journal:  Science       Date:  2018-12-06       Impact factor: 47.728

4.  Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.

Authors:  Gintautas Tamulaitis; Migle Kazlauskiene; Elena Manakova; Česlovas Venclovas; Alison O Nwokeoji; Mark J Dickman; Philippe Horvath; Virginijus Siksnys
Journal:  Mol Cell       Date:  2014-11-06       Impact factor: 17.970

5.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

6.  A Reverse Transcriptase-Cas1 Fusion Protein Contains a Cas6 Domain Required for Both CRISPR RNA Biogenesis and RNA Spacer Acquisition.

Authors:  Georg Mohr; Sukrit Silas; Jennifer L Stamos; Kira S Makarova; Laura M Markham; Jun Yao; Patricia Lucas-Elío; Antonio Sanchez-Amat; Andrew Z Fire; Eugene V Koonin; Alan M Lambowitz
Journal:  Mol Cell       Date:  2018-10-18       Impact factor: 17.970

7.  Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center.

Authors:  Alice R Wattam; James J Davis; Rida Assaf; Sébastien Boisvert; Thomas Brettin; Christopher Bun; Neal Conrad; Emily M Dietrich; Terry Disz; Joseph L Gabbard; Svetlana Gerdes; Christopher S Henry; Ronald W Kenyon; Dustin Machi; Chunhong Mao; Eric K Nordberg; Gary J Olsen; Daniel E Murphy-Olson; Robert Olson; Ross Overbeek; Bruce Parrello; Gordon D Pusch; Maulik Shukla; Veronika Vonstein; Andrew Warren; Fangfang Xia; Hyunseung Yoo; Rick L Stevens
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

8.  Comprehensive search for accessory proteins encoded with archaeal and bacterial type III CRISPR-cas gene cassettes reveals 39 new cas gene families.

Authors:  Shiraz A Shah; Omer S Alkhnbashi; Juliane Behler; Wenyuan Han; Qunxin She; Wolfgang R Hess; Roger A Garrett; Rolf Backofen
Journal:  RNA Biol       Date:  2018-06-19       Impact factor: 4.652

9.  Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.

Authors:  Lucas B Harrington; David Burstein; Janice S Chen; David Paez-Espino; Enbo Ma; Isaac P Witte; Joshua C Cofsky; Nikos C Kyrpides; Jillian F Banfield; Jennifer A Doudna
Journal:  Science       Date:  2018-10-18       Impact factor: 47.728

10.  CRISPR recognition tool (CRT): a tool for automatic detection of clustered regularly interspaced palindromic repeats.

Authors:  Charles Bland; Teresa L Ramsey; Fareedah Sabree; Micheal Lowe; Kyndall Brown; Nikos C Kyrpides; Philip Hugenholtz
Journal:  BMC Bioinformatics       Date:  2007-06-18       Impact factor: 3.169

View more
  12 in total

1.  Engineered CRISPR prime editors with compact, untethered reverse transcriptases.

Authors:  Julian Grünewald; Bret R Miller; Regan N Szalay; Peter K Cabeceiras; Christopher J Woodilla; Eliza Jane B Holtz; Karl Petri; J Keith Joung
Journal:  Nat Biotechnol       Date:  2022-09-26       Impact factor: 68.164

2.  UG/Abi: a highly diverse family of prokaryotic reverse transcriptases associated with defense functions.

Authors:  Mario Rodríguez Mestre; Linyi Alex Gao; Shiraz A Shah; Adrián López-Beltrán; Alejandro González-Delgado; Francisco Martínez-Abarca; Jaime Iranzo; Modesto Redrejo-Rodríguez; Feng Zhang; Nicolás Toro
Journal:  Nucleic Acids Res       Date:  2022-06-24       Impact factor: 19.160

3.  Identification and classification of reverse transcriptases in bacterial genomes and metagenomes.

Authors:  Fatemeh Sharifi; Yuzhen Ye
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 19.160

4.  Recruitment of Reverse Transcriptase-Cas1 Fusion Proteins by Type VI-A CRISPR-Cas Systems.

Authors:  Nicolás Toro; Mario Rodríguez Mestre; Francisco Martínez-Abarca; Alejandro González-Delgado
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

Review 5.  Retrons and their applications in genome engineering.

Authors:  Anna J Simon; Andrew D Ellington; Ilya J Finkelstein
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

Review 6.  CRISPR-Cas Systems and the Paradox of Self-Targeting Spacers.

Authors:  Franziska Wimmer; Chase L Beisel
Journal:  Front Microbiol       Date:  2020-01-22       Impact factor: 5.640

Review 7.  Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System.

Authors:  Matvey V Kolesnik; Iana Fedorova; Karyna A Karneyeva; Daria N Artamonova; Konstantin V Severinov
Journal:  Biochemistry (Mosc)       Date:  2021-10       Impact factor: 2.487

Review 8.  Eco-evolutionary significance of domesticated retroelements in microbial genomes.

Authors:  Blair G Paul; A Murat Eren
Journal:  Mob DNA       Date:  2022-02-23

9.  Distinct Expansion of Group II Introns During Evolution of Prokaryotes and Possible Factors Involved in Its Regulation.

Authors:  Masahiro C Miura; Shohei Nagata; Satoshi Tamaki; Masaru Tomita; Akio Kanai
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

Review 10.  Prokaryotic reverse transcriptases: from retroelements to specialized defense systems.

Authors:  Alejandro González-Delgado; Mario Rodríguez Mestre; Francisco Martínez-Abarca; Nicolás Toro
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.